• / Free eNewsletters & Magazine
  • / My Account


  1. A Push-Me, Pull-You Market

    Maxygen MAXY announced that its partner Roche RHHBY placed a hold on development of Maxy -Alpha--the first of Maxygen's shuffled proteins to enter clinical development--and we're lowering our fair value estimate accordingly. While we had only placed a 20% probability on the eventual approval of ...

  2. Five Things Your Credit Manager Shouldn’t Be Doing (But Probably Is)

    Early data from Maxygen's pipeline is encouraging, but key trials are just beginning.

  3. Choosing the Best 529 College Saving Plan

    Maxygen's pipeline is entering the clinic, but its technology remains unproven.

©2017 Morningstar Advisor. All right reserved.